These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 28723722)
1. Complementary and Alternative Medicine Use and Symptom Burden in Women Undergoing Chemotherapy for Breast Cancer in Malaysia. Chui PL; Abdullah KL; Wong LP; Taib NA Cancer Nurs; 2018; 41(3):189-199. PubMed ID: 28723722 [TBL] [Abstract][Full Text] [Related]
2. Prayer-for-health and complementary alternative medicine use among Malaysian breast cancer patients during chemotherapy. Chui PL; Abdullah KL; Wong LP; Taib NA BMC Complement Altern Med; 2014 Oct; 14():425. PubMed ID: 25358688 [TBL] [Abstract][Full Text] [Related]
3. Quality of Life in CAM and Non-CAM Users among Breast Cancer Patients during Chemotherapy in Malaysia. Chui PL; Abdullah KL; Wong LP; Taib NA PLoS One; 2015; 10(10):e0139952. PubMed ID: 26451732 [TBL] [Abstract][Full Text] [Related]
4. The use of complementary and alternative medicine among Chinese women with breast cancer. Chen Z; Gu K; Zheng Y; Zheng W; Lu W; Shu XO J Altern Complement Med; 2008 Oct; 14(8):1049-55. PubMed ID: 18928393 [TBL] [Abstract][Full Text] [Related]
5. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study. Greenlee H; Neugut AI; Falci L; Hillyer GC; Buono D; Mandelblatt JS; Roh JM; Ergas IJ; Kwan ML; Lee M; Tsai WY; Shi Z; Lamerato L; Kushi LH; Hershman DL JAMA Oncol; 2016 Sep; 2(9):1170-6. PubMed ID: 27243607 [TBL] [Abstract][Full Text] [Related]
6. Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia. Mohd Mujar NM; Dahlui M; Emran NA; Abdul Hadi I; Wai YY; Arulanantham S; Hooi CC; Mohd Taib NA PLoS One; 2017; 12(4):e0176394. PubMed ID: 28448541 [TBL] [Abstract][Full Text] [Related]
7. Use of Complementary and Alternative Medicine Among Newly Diagnosed Breast Cancer Patients in Malaysia: An Early Report From the MyBCC Study. Zulkipli AF; Islam T; Mohd Taib NA; Dahlui M; Bhoo-Pathy N; Al-Sadat N; Abdul Majid H; Hussain S; Integr Cancer Ther; 2018 Jun; 17(2):312-321. PubMed ID: 29218996 [TBL] [Abstract][Full Text] [Related]
8. Use of complementary and alternative medicine therapies to control symptoms in women living with lung cancer. Wells M; Sarna L; Cooley ME; Brown JK; Chernecky C; Williams RD; Padilla G; Danao LL Cancer Nurs; 2007; 30(1):45-55; quiz 56-7. PubMed ID: 17235219 [TBL] [Abstract][Full Text] [Related]
9. Frequency of use of complementary and alternative medicine in women with breast cancer. Lengacher CA; Bennett MP; Kip KE; Keller R; LaVance MS; Smith LS; Cox CE Oncol Nurs Forum; 2002; 29(10):1445-52. PubMed ID: 12432415 [TBL] [Abstract][Full Text] [Related]
10. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Henderson JW; Donatelle RJ Altern Ther Health Med; 2004; 10(1):52-7. PubMed ID: 14727500 [TBL] [Abstract][Full Text] [Related]
11. The use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive study. Helyer LK; Chin S; Chui BK; Fitzgerald B; Verma S; Rakovitch E; Dranitsaris G; Clemons M BMC Cancer; 2006 Feb; 6():39. PubMed ID: 16504038 [TBL] [Abstract][Full Text] [Related]
12. Latent class analysis suggests four distinct classes of complementary medicine users among women with breast cancer. Strizich G; Gammon MD; Jacobson JS; Wall M; Abrahamson P; Bradshaw PT; Terry MB; Teitelbaum S; Neugut AI; Greenlee H BMC Complement Altern Med; 2015 Nov; 15():411. PubMed ID: 26585912 [TBL] [Abstract][Full Text] [Related]
13. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. Boon HS; Olatunde F; Zick SM BMC Womens Health; 2007 Mar; 7():4. PubMed ID: 17397542 [TBL] [Abstract][Full Text] [Related]
14. Complementary Medicine Use, Symptom Burden and Non-Adherence in Kidney Transplant Recipients. Markell MS; Terebelo S Explore (NY); 2018 Nov; 14(6):414-419. PubMed ID: 30337196 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross- sectional study. Yarney J; Donkor A; Opoku SY; Yarney L; Agyeman-Duah I; Abakah AC; Asampong E BMC Complement Altern Med; 2013 Jan; 13():16. PubMed ID: 23331546 [TBL] [Abstract][Full Text] [Related]
16. Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer. Lengacher CA; Bennett MP; Kipp KE; Berarducci A; Cox CE Oncol Nurs Forum; 2003; 30(5):811-21. PubMed ID: 12949594 [TBL] [Abstract][Full Text] [Related]
17. Use of complementary and alternative medicine among breast cancer survivors. Saibul N; Shariff ZM; Rahmat A; Sulaiman S; Yaw YH Asian Pac J Cancer Prev; 2012; 13(8):4081-6. PubMed ID: 23098520 [TBL] [Abstract][Full Text] [Related]
18. Complementary alternative medicine use amongst breast cancer patients in the Northern region of peninsular Malaysia. Knight A; Hwa YS; Hashim H Asian Pac J Cancer Prev; 2015; 16(8):3125-30. PubMed ID: 25921108 [TBL] [Abstract][Full Text] [Related]
19. Breast cancer patients' perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation. Astin JA; Reilly C; Perkins C; Child WL; J Soc Integr Oncol; 2006; 4(4):157-69. PubMed ID: 17022924 [TBL] [Abstract][Full Text] [Related]
20. Effects of Complementary and Alternative Medicine on Chemotherapy Delivery in Thai Patients. Rabiltossaporn C; Wongchanapai P; Poovoravan N; Sitthideatphaiboon P; Sriuranpong V; Tanasanvimon S Asian Pac J Cancer Prev; 2021 Dec; 22(12):3977-3983. PubMed ID: 34967579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]